Cannabix TechnologiesFRA:8CT +7.14%32 5-Year ROIIC % is -644.67 as of Apr. 2025. GuruFocus rates FRA:8CT with a GF Score™ of 32/100. The stock has 2 warning signs investors should review. Among 733 Medical Devices & Instruments companies, Cannabix Technologies ranks worse than 98.23% on this metric.
5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year.
Cannabix Technologies's 5-Year ROIIC % for the quarter that ended in Apr. 2025 was -644.67%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Cannabix Technologies's 5-Year ROIIC % or its related term are showing as below:
FRA:8CT's 5-Year ROIIC % is ranked worse than 98.23% of 733
companies
in the Medical Devices & Instruments industry
Industry Median: 1.04
vs FRA:8CT: -644.67
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Cannabix Technologies 5-Year ROIIC % Related Terms
Cannabix Technologies 5-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Cannabix Technologies's 5-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:8CT vs ABT, SYK, MDT: 5-Year ROIIC % Comparison
For the Medical Devices subindustry, Cannabix Technologies's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cannabix Technologies 5-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cannabix Technologies's 5-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Cannabix Technologies's 5-Year ROIIC % falls into.
Cannabix Technologies's 5-Year ROIIC % for the quarter that ended in Apr. 2025 is calculated as:
5-Year ROIIC %
=
5-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
5-Year Incremental Invested Capital**
=
( -3.027 (Apr. 2025) - -2.084 (Apr. 2020) )
/
( 0.287 (Apr. 2025) - 0.136 (Apr. 2020) )
=
-0.943
/
0.151
=
-624.50%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Cannabix Technologies (FRA:8CT) has a 5-Year ROIIC % of -644.67 as of Apr. 2025. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Cannabix Technologies and its competitors. According to the industry distribution chart, Cannabix Technologies ranks #720 out of 733 companies in the Medical Devices & Instruments industry, placing it in the top 98.2%.
Is Cannabix Technologies' 5-Year ROIIC % too high?
Cannabix Technologies' current 5-Year ROIIC % is -644.67. Based on the distribution chart, Cannabix Technologies ranks #720 out of 733 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Cannabix Technologies has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Cannabix Technologies' 5-Year ROIIC % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Cannabix Technologies ranks #720 out of 733 companies for 5-Year ROIIC %. This places Cannabix Technologies in the lower half of its industry. The industry median 5-Year ROIIC % is 1.04. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year ROIIC % for a Medical Devices & Instruments company?
The median 5-Year ROIIC % among Medical Devices & Instruments companies is 1.04, based on 733 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year ROIIC % mean?
A high 5-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Cannabix Technologies and its competitors. For the Medical Devices & Instruments industry, the median 5-Year ROIIC % is 1.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cannabix Technologies's current 5-Year ROIIC % is -644.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabix Technologies stock overvalued right now?
Cannabix Technologies (FRA:8CT) has a current 5-Year ROIIC % of -644.67. The current 5-Year ROIIC % is -644.67. Cannabix Technologies' overall GF Score™ is 32/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year ROIIC % calculated?
5-Year ROIIC % is calculated from a company's financial statements. For Cannabix Technologies (FRA:8CT), the current 5-Year ROIIC % is -644.67 as of Apr. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cannabix Technologies Inc is engaged in the development of marijuana and alcohol breath testing technologies. Its products are Cannabix Marijuana Breath Test and BreathLogix Alcohol Breathalyzer.
32GF Score
Get the complete analysis for FRA:8CT
5-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:8CT has been successfully added to your 
